DV
Dividend Vision

IBIO — iBio, Inc.

iBio, Inc. (IBIO)

Total return is -100.0% over the past 18 years, 849.9 points behind SPY at 749.9%. Its deepest 1-year drawdown was 56.0%.

IBIO is a healthcare equity stock that trades as a single security rather than functioning as a traditional diversified ETF. With no reported distribution rate, expense ratio, or assets under management, this holding does not generate regular dividend income and lacks the transparency typical of actively managed or indexed dividend funds. It may appeal to investors seeking direct exposure to biotech or healthcare companies, though it does not serve as an income-generating vehicle for dividend-focused portfolios.

IBIO key facts

Asset type
Stock
Asset class
Equity
Inception date
08/19/2008
Last close
$1.43
Market cap
$71,040,336
Average volume
521800.0
Payment date
06/11/2018
Beta
1.306
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.56